Stacy Ann Coen is VP at ImmunoGen, Inc. (IMGN). They have made 2 open-market trades across 1 company since 2023, most recently 2024-02-12.
CIK 0001814150
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGN | 77,857 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2024-02-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGN | SELL · 10b5-1 | 2024-02-05 | 2024-02-06 | $29.30 | $269K | N/A | N/A | N/A |
| IMGN | SELL · 10b5-1 | 2023-11-30 | 2023-12-05 | $29.20 | $223K | +0.9% | +1.1% | N/A |
| IMGN | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $16.04 | $3.4M | +87.4% | +88.2% | N/A |
| IMGN | SELL | 2023-08-09 | 2023-08-11 | $14.20 | $1.4M | +14.3% | +10.2% | +3.7% |
| IMGN | SELL | 2023-08-02 | 2023-08-04 | $17.10 | $2.9M | -4.2% | -8.0% | -7.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.